查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
自测试市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按测试类型、样本、用途、分销渠道、地区和竞争细分
市场调查报告书
商品编码
1326473

自测试市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按测试类型、样本、用途、分销渠道、地区和竞争细分

Self Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Test Type, By Sample, By Usage, By Distribution Channel, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计全球自我测试市场在预测期内将以惊人的速度增长。由于这些产品的便利性和可获取性，以及技术的进步使它们更加准确和可靠，该市场变得越来越受欢迎。推动全球自测市场增长的主要因素之一是这些产品提供的便利性和可访问性。消费者现在可以在舒适的家中监测自己的健康状况，而无需医疗保健专业人员。对于那些日程繁忙、行动不便或居住在偏远地区的人来说，这种便利尤其有吸引力。此外，全世界人民的健康意识不断增强。消费者对自己的健康变得更加积极主动，并正在寻找监测和改善健康的方法。自检产品提供了一种追踪血糖、胆固醇和血压等健康指标的便捷方法，可以帮助消费者就自己的健康做出明智的决定。反过来，这预计将支持全球自测市场的增长。

负担能力

自检产品往往比传统医疗保健服务更具成本效益，这也促进了其受欢迎。消费者可以通过在家监测自己的健康状况来省钱，而不用支付昂贵的医疗检查或看医生的费用。此外，部分自检产品还享受保险，进一步降低了消费者的成本。反过来，预计这将支持未来几年全球自测试市场的需求。

个性化

由于这些产品提供的个性化功能，全球自测市场在过去几年中不断增长。消费者可以从各种满足其个人需求的自测产品中进行选择，例如监测血糖水平以进行糖尿病管理或跟踪排卵以进行生育计划。这种个性化使消费者能够掌控自己的健康，并根据自己的独特情况做出明智的决定。此外，除了选择测试的人之外，测试结果也不为其他任何人所知，从而支持了全球自测市场的增长。

慢性病患病率不断上升

心血管疾病和糖尿病等慢性疾病的日益流行预计将支持自检市场的增长，直至 2028 年。美国是世界第三大糖尿病人口的所在地。美国约有 3030 万成年人患有糖尿病，几乎每 10 名成年人中就有 1 人患有糖尿病。心血管疾病是美国的首要死因，2019 年报告的死亡人数约为 659,041 人。导致心血管疾病的主要因素是糖尿病和高胆固醇。反过来，预计这将增加全球自我检测市场对血糖检测和胆固醇检测部分的需求。

远程医疗的日益普及

远程医疗和远程患者监测的日益普及增加了对家庭检测套件的需求，从而推动了全球自我诊断市场的增长。远程医疗的出现使患者转向家庭诊断，特别是对于需要持续监测血糖水平的糖尿病患者。糖尿病患者使用家用检测套件在家检查血糖水平，然后通过电话或视频通话咨询医生。这反过来又减少了患者去诊所和医院的需要。不断增长的糖尿病人口将进一步支持全球自我检测市场的增长。根据国际糖尿病联合会的数据，截至 2021 年，大约有 5.37 亿成年人（20-79 岁）患有糖尿病。预计到 2030 年，糖尿病患者总数将增至 6.43 亿，到 2045 年将增至 7.83 亿。

基因检测

近年来，基因测试也变得越来越广泛，公司提供的测试可以提供有关广泛遗传特征和健康风险的信息。这些测试可以在家中进行，并为消费者提供有关其基因构成的个性化信息。这些信息可用于就他们的健康和保健做出明智的决定，例如改变生活方式或寻求医疗干预措施。

近年来，随着人们寻求更好地了解自己的健康和血统，基因测试变得越来越流行。技术的进步使个人可以在线订购基因检测试剂盒并在舒适的家中进行检测。这些家庭基因检测产品为人们提供了一种方便且负担得起的方式来更多地了解他们的基因构成和潜在的健康风险。有许多不同的公司提供家庭使用的基因检测试剂盒，包括 23andMe、AncestryDNA 和 MyHeritage。这些公司为个人提供简单的唾液采集套件，他们可以用它来提供 DNA 样本。然后样本被送往实验室进行分析，通常在几週内即可获得结果。这些公司提供的测试可以提供有关个人基因构成的大量信息。例如，他们可以识别与某些疾病风险增加相关的特定遗传变异，例如帕金森病、阿尔茨海默病和乳腺癌。他们还可以提供有关个人血统和家谱的信息，这对那些有兴趣追踪家族史的人很有帮助。反过来，这有望为全球自测市场的增长创造新的前景。

最近的发展

  • Premom 于 2021 年推出了排卵预测套件，让女性可以在家跟踪自己的生育能力。该套件包括排卵试纸和智能手机应用程序，可分析结果以提供有关排卵模式和生育状态的个性化见解。 Premom 排卵预测套件因其准确性和易用性而受到讚誉。
  • Cue Health 于 2020 年推出了可在家进行的快速 COVID-19 检测。该测试使用鼻拭子和一个连接到智能手机的紧凑设备，只需 20 分钟即可提供结果。 Cue Health COVID-19 测试已获得 FDA 授权紧急使用，并正在学校、工作场所和医疗机构中使用。
  • Ellume, Inc. 于 2020 年推出了可在家进行的快速 COVID-19 测试。该测试使用鼻拭子和小型分析仪，只需 15 分钟即可得出结果。 Ellume COVID-19 测试已获得 FDA 授权紧急使用，并正在学校、工作场所和医疗机构中使用。
  • 2019年，23andMe, Inc.推出了健康+祖先服务，为消费者提供有关其遗传特征和健康风险的信息。该服务包括超过 125 份有关健康状况的报告，例如乳腺癌和心脏病，以及遗传性疾病的携带者状况。
  • Abbott Laboratories, Inc. 于 2019 年推出了 Libre 2 连续血糖监测 (CGM) 系统。该设备佩戴在上臂背部，提供实时血糖读数以及高或低血糖水平警报。 Libre 2 还具有蓝牙连接功能，允许用户与医疗保健提供者和护理人员共享血糖数据。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球自测市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按测试类型（血糖测试、妊娠和生育测试、胆固醇测试、尿液测试、COVID-19 测试、其他）
    • 样本（血液、尿液、唾液）
    • 按用途分类（一次性与可重复使用）
    • 按分销渠道（零售店/零售药店、医院药房、大卖场/超市、电子商务渠道/网上药店）
    • 按地区
    • 按公司划分 (2022)
  • 产品图
    • 按测试类型
    • 按样品
    • 按用途
    • 按分销渠道
    • 按地区

第 6 章：北美自测市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按测试类型
    • 按样品
    • 按用途
    • 按分销渠道
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲自测市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按测试类型
    • 按样品
    • 按用途
    • 按分销渠道
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太自测市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按测试类型
    • 按样品
    • 按用途
    • 按分销渠道
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章：南美自测市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按测试类型
    • 按样品
    • 按用途
    • 按分销渠道
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲自测市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按测试类型
    • 按样品
    • 按用途
    • 按分销渠道
    • 按国家/地区
  • MEA：国家分析
    • 南非自测
    • 沙特阿拉伯自测
    • 阿联酋自测

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球自测市场：SWOT 分析

第 14 章：波特的五力分析

  • 行业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 服务内容
  • 最近的发展
  • 主要人员
  • SWOT分析
    • Lucira Health, Inc.
    • Essenlix Corporation
    • Abbott Laboratories, Inc.
    • Quidel Corporation
    • ACON Laboratories, Inc.
    • Scanwell Health, Inc.
    • Johnson & Johnson
    • Geratherm Medical AG
    • B. Braun Holding GmbH
    • OraSure Technologies, Inc.
    • bioLytical Laboratories Inc.
    • Bionime Corporation
    • Becton, Dickinson & Company
    • PRIMA Lab SA
    • F. Hoffmann-La Roche AG

第 16 章：战略建议

简介目录
Product Code: 14871

Global Self Testing Market is expected to grow at an impressive rate during the forecast period. This market has become increasingly popular due to the convenience and accessibility of these products, as well as advances in technology that have made them more accurate and reliable. One of the primary factors driving the growth of the global self-testing market is the convenience and accessibility that these products offer. Consumers can now monitor their health from the comfort of their own homes without the need for a healthcare professional. This convenience is particularly attractive for those with busy schedules, mobility issues, or who live in remote areas. Additionally, the increasing awareness of health and wellness among the population worldwide. Consumers are becoming more proactive about their health and are seeking out ways to monitor and improve their well-being. Self-testing products provide a convenient way to track health indicators such as blood sugar, cholesterol, and blood pressure, which can help consumers make informed decisions about their health. This, in turn, is expected to support the growth of global self-testing market.

Affordability

Self-testing products are often more cost-effective than traditional healthcare services, which has also contributed to their popularity. Consumers can save money by monitoring their health at home instead of paying for expensive medical tests or doctor's visits. Additionally, some self-testing products are covered by insurance, which further reduces costs for consumers. This, in turn, is expected to support the demand for global self-testing market in the coming years.

Personalization

Global self-testing market has grown over the last few years due to the personalization that these products offer. Consumers can choose from a wide range of self-testing products that cater to their individual needs, such as monitoring blood sugar levels for diabetes management or tracking ovulation for fertility planning. This personalization allows consumers to take control of their health and make informed decisions based on their unique circumstances. Additionally, the test results are also not known to anyone else except the one opting for the test, thereby supporting the growth of global self-testing market.

The self-testing kits are highly useful in fertility testing. Home testing kits can provide information on ovulation and fertility status, enabling women to plan their families and make informed decisions about their reproductive health. Fertility testing has traditionally been performed in a clinical setting, but new products have made it possible for women to test their fertility at home. This, in turn, is expected to drive the growth of global self-testing market.

Growing Prevalence of Chronic Diseases

The growing prevalence of chronic diseases such as cardiovascular diseases and diabetes is expected to support the self-testing market growth through 2028. The United States is home to the world's third-largest diabetic population. Around 30.3 million adults in the United States are suffering from diabetes which is almost 1 in 10 adults. Cardiovascular diseases are the leading cause of death in the United States, with around 659,041 reported deaths in 2019. The major factors contributing to cardiovascular diseases are diabetes and high cholesterol. This, in turn, is expected to increase the demand for blood glucose testing and cholesterol testing segment of global self-testing market.

Growing Adoption of Telemedicine

The growing adoption of telemedicine and remote patient monitoring increased the demand for at-home testing kits, thereby driving the growth of global self-diagnostics market. The advent of telemedicine made patients switch to at-home diagnostics, especially in the case of patients suffering from diabetes who continuously need to monitor their blood glucose levels. Diabetic patients using at-home testing kits check their blood glucose levels at home and then consult their doctor over the phone or video call. This, in turn, has reduced the need for patients to visit clinics and hospitals. The growing diabetic population will further support the growth of global self-testing market. According to International Diabetes Federation, as of 2021, Approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

Genetic Testing

Genetic testing has also become more widely available in recent years, with companies offering tests that can provide information on a wide range of genetic traits and health risks. These tests can be performed at home and provide consumers with personalized information on their genetic makeup. This information can be used to make informed decisions about their health and wellness, such as making lifestyle changes or seeking out medical interventions.

Genetic testing has become increasingly popular in recent years as people seek to better understand their health and ancestry. Advances in technology have made it possible for individuals to order genetic testing kits online and perform the tests in the comfort of their own homes. These at-home genetic testing products provide people with a convenient and affordable way to learn more about their genetic makeup and potential health risks. There are many different companies that offer genetic testing kits for use at home, including 23andMe, AncestryDNA, and MyHeritage. These companies provide individuals with a simple saliva collection kit that they can use to provide a DNA sample. The samples are then sent to a laboratory for analysis, and the results are usually available within a few weeks. The tests offered by these companies can provide a wealth of information about an individual's genetic makeup. For example, they can identify specific genetic variants that are associated with an increased risk of certain diseases, such as Parkinson's disease, Alzheimer's disease, and breast cancer. They can also provide information about an individual's ancestry and genealogy, which can be helpful for those interested in tracing their family history. This, in turn, is expected to create new prospects for the growth of global self-testing market.

Market Segmentation

Global Self Testing Market can be segmented by test type, sample, usage, distribution channel, and region. Based on test type, the global self-testing market can be categorized into blood glucose testing, pregnancy & fertility testing, cholesterol testing, urine testing, COVID-19 testing, and others. By sample, the global self-testing market can be categorized into blood, urine, and saliva. By usage, the global self-testing market can be split into disposable and reusable. In terms of distribution channels, the global self-testing market can be segmented into retail stores/retail pharmacies, hospital pharmacies, hypermarkets/supermarket, and e-commerce channels/online pharmacies. Regionally, the global self testing market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Lucira Health, Inc., Essenlix Corporation, Abbott Laboratories, Inc., Quidel Corporation, ACON Laboratories, Inc., Scanwell Health, Inc., Johnson & Johnson, Geratherm Medical AG, B. Braun Holding GmbH, OraSure Technologies, Inc., bioLytical Laboratories Inc., Bionime Corporation, Becton, Dickinson & Company, PRIMA Lab SA, F. Hoffmann-La Roche AG, among others are some of the leading players operating in the global Self Testing market.

Recent Developments

  • Premom launched its ovulation prediction kit in 2021, which allows women to track their fertility at home. The kit includes ovulation test strips and a smartphone app that analyzes the results to provide personalized insights into ovulation patterns and fertility status. The Premom ovulation prediction kit has been praised for its accuracy and ease of use.
  • Cue Health launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a compact device that connects to a smartphone to provide results in just 20 minutes. The Cue Health COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • Ellume, Inc. launched a rapid COVID-19 test in 2020 that can be performed at home. The test uses a nasal swab and a small analyzer device that provides results in just 15 minutes. The Ellume COVID-19 test has been authorized by the FDA for emergency use and is being used in schools, workplaces, and healthcare settings.
  • In 2019, 23andMe, Inc. launched its Health + Ancestry service, which provides consumers with information on their genetic traits and health risks. The service includes more than 125 reports on health conditions, such as breast cancer and heart disease, as well as carrier status for inherited conditions.
  • Abbott Laboratories, Inc. launched the Libre 2 continuous glucose monitoring (CGM) system in 2019. The device is worn on the back of the upper arm and provides real-time glucose readings and alerts for high or low blood sugar levels. The Libre 2 also has Bluetooth connectivity, allowing users to share their glucose data with healthcare providers and caregivers.

Report Scope:

In this report, Global Self Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Self Testing Market, By Test Type:

  • Blood Glucose Testing
  • Pregnancy & Fertility Testing
  • Cholesterol Testing
  • Urine Testing
  • COVID-19 Testing
  • Others

Self Testing Market, By Sample:

  • Blood
  • Urine
  • Saliva

Self-Testing Market, By Usage:

  • Disposable
  • Reusable

Self-Testing Market, By Distribution Channel:

  • Retail Stores/Retail Pharmacies
  • Hospital Pharmacies
  • Hypermarket/Supermarket
  • E-Commerce Channels/Online Pharmacies

Self-Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Self Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Self Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others)
    • 5.2.2. By Sample (Blood, Urine, Saliva)
    • 5.2.3. By Usage (Disposable v/s Reusable)
    • 5.2.4. By Distribution Channel (Retail Stores/Retail Pharmacies, Hospital Pharmacies, Hypermarket/Supermarket, E-Commerce Channels/Online Pharmacies)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Product Map
    • 5.3.1. By Test Type
    • 5.3.2. By Sample
    • 5.3.3. By Usage
    • 5.3.4. By Distribution Channel
    • 5.3.5. By Region

6. North America Self Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test Type
    • 6.2.2. By Sample
    • 6.2.3. By Usage
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Self Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test Type
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Usage
        • 6.3.1.2.4. By Distribution Channel
    • 6.3.2. Canada Self Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test Type
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Usage
        • 6.3.2.2.4. By Distribution Channel
    • 6.3.3. Mexico Self Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test Type
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Usage
        • 6.3.3.2.4. By Distribution Channel

7. Europe Self Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By Sample
    • 7.2.3. By Usage
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Self Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test Type
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Usage
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Germany Self Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test Type
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Usage
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. United Kingdom Self Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Test Type
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Usage
        • 7.3.3.2.4. By Distribution Channel
    • 7.3.4. Italy Self Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test Type
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Usage
        • 7.3.4.2.4. By Distribution Channel
    • 7.3.5. Spain Self Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test Type
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Usage
        • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Self Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test Type
    • 8.2.2. By Sample
    • 8.2.3. By Usage
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Self Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test Type
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Usage
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. India Self Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test Type
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Usage
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. Japan Self Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test Type
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Usage
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. South Korea Self Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test Type
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Usage
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Australia Self Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test Type
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Usage
        • 8.3.5.2.4. By Distribution Channel

9. South America Self Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test Type
    • 9.2.2. By Sample
    • 9.2.3. By Usage
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Self Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test Type
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Usage
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. Argentina Self Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test Type
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Usage
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Colombia Self Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test Type
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Usage
        • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Self Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test Type
    • 10.2.2. By Sample
    • 10.2.3. By Usage
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Self Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test Type
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Usage
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Self Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test Type
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Usage
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Self Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test Type
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Usage
        • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Self Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Lucira Health, Inc.
    • 15.5.2. Essenlix Corporation
    • 15.5.3. Abbott Laboratories, Inc.
    • 15.5.4. Quidel Corporation
    • 15.5.5. ACON Laboratories, Inc.
    • 15.5.6. Scanwell Health, Inc.
    • 15.5.7. Johnson & Johnson
    • 15.5.8. Geratherm Medical AG
    • 15.5.9. B. Braun Holding GmbH
    • 15.5.10. OraSure Technologies, Inc.
    • 15.5.11. bioLytical Laboratories Inc.
    • 15.5.12. Bionime Corporation
    • 15.5.13. Becton, Dickinson & Company
    • 15.5.14. PRIMA Lab SA
    • 15.5.15. F. Hoffmann-La Roche AG

16. Strategic Recommendations